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Abstract
In vitro studies have suggested that isolated gut bacteria are able to metabolize PUFA into CLA (conjugated linoleic acids)
and CLnA (conjugated linolenic acids). However, the bioavailability of fatty acid metabolites produced in vivo by the gut
microbes remains to be studied. Therefore, we measured intestinal concentration and plasma accumulation of bacterial
metabolites produced from dietary PUFA in mice, first injected with a lipoprotein lipase inhibitor, then force-fed with either
sunflower oil (200 ml) rich in n-6 PUFA or linseed oil (200 ml) rich in n-3 PUFA. The greatest production of bacterial
metabolites was observed in the caecum and colon, and at a much lesser extent in the jejunum and ileum. In the caecal
content, CLA proportions were higher in sunflower oil force-fed mice whereas CLnA proportions were higher in linseed oil
force-fed mice. The accumulation of the main metabolites (CLA cis-9,trans-11-18:2 and CLnA cis-9,trans-11,cis-15-18:3) in the
caecal tissue was not associated with their increase in the plasma, therefore suggesting that, if endogenously produced CLA
and CLnA have any biological role in host metabolism regulation, their effect would be confined at the intestinal level,
where the microbiota is abundant.
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Introduction
The trillions of bacteria housed in our gastro-intestinal tract
play an essential role in host homeostasis. This bacterial
population was shown to be able to modulate the host’s energy
metabolism [1], inflammation [2,3] and immunity [4]. The
interactions between bacteria and their host are mediated, among
others, by metabolites produced by the bacteria [5]. Due to the
huge size of the microbiome, a very high metabolic potential of the
gut microbiota could be envisaged. The contribution of bacteria to
fatty acid metabolism has been mostly and largely studied in
ruminants [6]. In vitro studies showed that gut bacteria isolated
from humans are also able to metabolize linoleic acid (LA) and a-
linolenic acid (a-LnA) into metabolites like conjugated linoleic
acids (CLA), conjugated linolenic acids (CLnA), and other trans
fatty acids such as vaccenic acid (trans-11-18:1) [7–9]. These in vitro
studies have shown that the main PUFA-derived bacterial
metabolites are rumenic acid (CLA cis-9,trans-11-18:2), vaccenic
acid (trans-11-18:1), CLnA cis-9,trans-11,cis-15-18:3 and trans-11,cis-
15-18:2 [7,8]. But these in vitro studies and the data from the
biohydrogenation pathways of LA and a-LnA, which are quite
well characterized in ruminants, suggest that other minor
metabolites could also be produced such as CLA trans-10,cis-12-
18:2; CLA trans-9,trans-11-18:2 and CLA cis-9,cis-11-18:2 [7,9–11].
Interesting properties were attributed to dietary supplementa-
tion with chemically produced conjugated fatty acids isomers both
in rodents and humans. Dietary supplementation with CLA
(mainly cis-9,trans-11-18:2 or trans-10,cis-12-18:2 or a combination
of both) was associated with anti-obesity, anti-atherogenic and
anti-inflammatory properties [12,13]. CLA also inhibited growth
of cancer cells in vitro [14]. Similarly, CLnA, produced by
Bifidobacterium breve, were able to inhibit the growth of human
colon cancer cells and could be associated with an anti-obesity
effect [15,16]. However, some effects of both CLA and CLnA
seem to be isomer-specific and the conclusion about these effects
should be cautiously interpreted [17–20]. In addition to these
health effects attributed to CLA and CLnA, it seems that other
bacterial metabolites such as vaccenic acid and very long chain
conjugated PUFA could also be associated with beneficial effects
towards the host [21,22].
In fact, CLA-producing bacteria are detected in the human gut
microbiota, suggesting that PUFA-derived bacterial metabolites
production may take place in the human gut. In vitro studies
confirm this, as bacteria isolated from human gut are able to
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produce both CLA and CLnA [7–9]. Our hypothesis is that
metabolites endogenously produced by the gut microbiota from
dietary PUFA could be a new kind of metabolites able to influence
host’s physiology. We proposed to test this hypothesis in mice,
which possess in their gut microbiota, the bacteria able to produce
PUFA metabolites in both human and animals (Lactobacilli,
Bifidobacteria, Roseburia) [9].
In a previous study, we have shown that CLA can be found in
the liver and adipose tissue of mice fed a high-fat (HF) diet, and
that the dietary supplementation of fermentable carbohydrates
with prebiotic properties, modulates proportion of CLA and lipid
derived metabolites in the adipose tissue [23]. This suggests that
CLA can be endogenously produced in vivo, but there is no clear
view of the availability of the PUFA-derived bacterial metabolites,
and of the nature of the fatty acid metabolites that can be
produced from different fatty acid precursors (n-3 versus n-6
PUFA, i.e.).
One challenging question raised by our previous results is to
identify whether bacterial metabolites are produced in the upper
and/or in the distal part of the gut, and if they can be absorbed.
The upper parts of the gut contain fewer bacteria than the distal
parts of the gut (103–104 bacteria/gram of jejunum content versus
1011–1012 bacteria/gram of colon content) [24–26]. However, the
jejunum remains the main site of fatty acid absorption [27]. The
distal parts of the gut contain the highest number of bacteria but
the potential contribution of the caecum and colon to fatty acid
absorption remains poorly studied.
The aim of this study was to investigate the production of
PUFA-derived bacterial metabolites in the contents and tissues of
different sites of the intestine of mice having received a single oral
load of either linseed oil (rich in n-3 PUFA) or sunflower oil (rich in
n-6 PUFA). PUFA-derived bacterial metabolites absorption and
bioavailability has been assessed by analyzing fatty acid metabo-
lites accumulation in the blood after pharmacological blocking of
lipoprotein lipase activity (Tyloxapol) to avoid tissue uptake and
distribution.
Materials and Methods
Ethics Statement
The ethical committee for animal care of the Health Sector of
the Universite´ catholique de Louvain, under the supervision of
prof. F. Lemaigre et J.P. Dehoux under the specific number 2010/
UCL/MD022, has specifically approved the animal experiments
performed in this study. Housing conditions were as specified by
the Belgian Law of 29 May 2013, on the protection of laboratory
animals (agreement nu LA 1230314).
Animals and diets
Male C57bl6/J mice (Charles River Laboratories, France) of 9
weeks old at the beginning of the experiment, were housed in a
controlled environment (12 h daylight, lights off at 6p.m.) with free
access to diet (AO4, SAFE, Villemoisson-sur-Orge, France) and
water. After one week of acclimatization and a 16-h period of
fasting, mice were injected with the lipoprotein lipase (LPL)
inhibitor Tyloxapol (iv retro-orbital injection, 0.5 mg/g of body
weight; Sigma-Aldrich) under light anesthesia (Isoflurane; Forene,
Abbott, Queenborough, Kent, England). Tyloxapol injection
results in an accumulation of lipids in the blood [28]. This
accumulation of lipids should allow to assess the fatty acid profile
of the circulating lipids in relation to their absorption rate. Thirty
minutes after Tyloxapol injection, mice were force-fed with
vegetable oils (200 ml). Six mice received sunflower oil and the
other six received linseed oil. We analyzed the fatty acid profile of
both vegetable oils by gas chromatography equipped with a flame-
ionization detector (GC-FID) (Table 1).
Blood and tissue samples
Blood from the tail vein was sampled before the Tyloxapol
injection (T-30), before oil force-feeding (T0), and ten minutes
(T10) and 2 hours (T120) after oil force-feeding. Four hours after
force-feeding (T240), mice were anesthetized with isoflurane gaz
(Forene, Abbott, Queenborough, Kent, England). Blood from
portal vein and cava vein was harvested for further analysis. The
blood was centrifuged (5 min, 13000 g) and plasma was stored at -
20uC. Mice were killed by cervical dislocation. Jejunum was
sampled 4 cm after the stomach, ileum was sampled just before the
caecum and the colon was sampled just after the caecum.
Intestinal contents were carefully collected and frozen in liquid
nitrogen before storage at 280uC. Then, all intestinal tissue
samples (jejunum, ileum, caecum and colon) were flushed and
carefully washed with cold saline solution (NaCl 0.9%) before
being frozen in liquid nitrogen and storage at 280uC.
Fatty acid profile analysis
To determine the fatty acid profile in intestinal tissues and
intestinal contents, we weighed 25 mg of jejunum, ileum and colon
contents, 50 mg of caecal content and 50 mg of intestinal tissues
(jejunum, ileum, caecum and colon). To determine the fatty acid
profile in blood, 50 ml of plasma was used. The tissues, contents
and blood samples were homogenized in a methanol:chloroform
mixture (1:2 V/V). Homogenates were filtered with Whatman
filters Nu1 (porosity 10 mm). The filters were rinsed with 2 ml of
chloroform and 1 ml of methanol. Homogenates were purified
successively with KCl 0.88% and KCl 0.88%:methanol (1:1 V/V).
After centrifugation (1500 g, 5 min), the chloroform phase was
collected in new tubes and evaporated under a nitrogen flux.
The esterified fatty acids were then subjected to an alkaline
hydrolysis (saponification). For that purpose, a solution of KOH in
methanol was added and incubated at 70uC for 1 hour. The free
fatty acids were methylated as follows: 0.4 ml of HCl in methanol
(1.2 M) was added in the tube and incubated at 70uC for 20
Table 1. Fatty acid profile of linseed and sunflower oils.
Linseed Oil Sunflower Oil
16:0 5,42 6,53
cis-9-16:1 0,11 0,14
18:0 4,10 3,15
cis-9-18:1 22,04 24,38
cis-11-18:1 0,70 0,77
cis-9,trans-12-18:2 ND 0,39
trans-9,cis-12-18:2 ND 0,33
cis-9,cis-12-18:2 (LA) 15,80 63,12
20:0 0,22 0,27
cis-9,cis-12,cis-15-18:3 (a-LnA) 50,79 0,06
trans-9,trans-11-18:2 ND 0,04
cis-9-20:1 0,25 0,21
22:0 0,18 0,68
The results are expressed as a percentage of the identified fatty acids (n.d.: not
detectable, below the level of detection). Only the isomers above the limit of
detection were presented in this Table 1.
doi:10.1371/journal.pone.0087560.t001
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minutes. Fatty acid methyl esters (FAME) were then extracted with
hexane.
To determine the fatty acid profile in oils, 15 mg of oil was
subjected to an alkaline hydrolysis and the free fatty acids were
methylated following the procedures described above.
Quantification of FAME was made by gas-liquid chromatog-
raphy (Focus GC, Thermo-Finnigan, Interscience, Belgium). The
chromatograph was equipped with a flame ionization detector and
a 100 m capillary column (i.d. 0.25 mm, film thickness 0.20 mm;
RT-2560, Restek, Interscience, Belgium) using H2 as the carrier
gas at a constant flow of 1.5 ml/min. The initial oven temperature
was 80uC, increased at 25uC/min to 175uC (held for 10 min), then
increased at 1uC/min to 200uC (held for 15 min), then increased
at 5uC/min to 215uC (held for 5 min) and finally decreased at
20uC/min to 80uC. The temperature of the flame ionization
detector was maintained at 250uC. The identification of each peak
was made by comparison of retention times with pure FAME
standards (Larodan Fine Chemicals AB, Malmo¨, Sweden). Peak
identification was further confirmed by an analysis of samples (oils,
caecum contents and caecum tissues) using a GC method
combining two different temperature programs following the
procedure described below. Composition analysis of FAME was
carried out by a gas chromatograph (HP 6890A, Agilent
Technologies, Diegem, Belgium) equipped with a 75-m SP-
2560TM capillary column (i.d. 0.18 mm, film thickness, 0.14 mm;
Supelco Analytical, Bellefonte, PA) and a flame ionization
detector. A combination of two oven temperature programs was
used in this study to achieve determination of most cis and trans
16:1, branched chain fatty acids and 18:1 isomers according to the
method of Kramer et al. [29] with modifications [30]. Most
FAME peaks were identified using quantitative mixtures of methyl
ester standards (BR2 and BR3, Larodan Fine Chemicals, Malmo¨,
Sweden; SupelcoH 37, Supelco Analytical, Bellefonte, PA; PUFA-
3, Matreya LLC, Pleasant Gap, PA). Fatty acids for which no
standards were available commercially were identified by order of
elution according to Precht et al. [31] and Kramer et al. [29].
Also, aliquots of methylated samples were pooled and subsequent-
ly fractionated by TLC on silica gel plates impregnated with silver
nitrate according to Destaillats et al [32] with modifications, in
order to confirm purity for peaks of interest in chromatograms and
to eliminate peaks that were not fatty acids (e.g. dimethyl acetals).
Blood lipids analysis
Plasma triglycerides and non-esterified fatty acids (NEFA)
concentrations were measured using kits coupling enzymatic
reaction and spectrophotometric detection of reaction end-
products (Diasys Diagnostic and Systems, Germany and Randox
Laboratories Limited, United Kingdom), according to the
manufacturer’s instructions.
Statistical analysis
Results are presented as mean6 SEM (standard error of mean).
Linear mixed-effects model followed by contrasts assessed the
statistical difference between both the two different oil force-
feedings and the different intestinal contents or the different
intestinal tissues or the different blood sample times (SPSS, version
20.0). For the fatty acid analyzed only in linseed oil force-fed mice,
the statistical significance of difference between the different
intestinal contents, intestinal tissues or blood sample times were
assessed by one-way ANOVA followed by Bonferroni’s post-hoc
multiple comparison test (GraphPad Prism Software). Statistical
significance was defined for a p-value lower than 0.05.
Results
Fatty acid characterization of linseed and sunflower oils
Sunflower oil was selected upon its high content in n-6 PUFA
(LA) and the linseed oil for its high content in n-3 PUFA (a-LnA)
[33]. GC-FID analysis of the oils confirmed that a-LnA represents
about 50% of the fatty acids identified in the linseed oil whereas it
represents only 0.06% of the fatty acids identified in the sunflower
oil (Table 1). LA represents 63% of the total fatty acids identified
in the sunflower oil whereas it represents only 16% of the total
fatty acids identified in the linseed oil (Table 1). The linseed oil is
thus characterized by a low ratio LA/a-LnA (0.3) whereas the
sunflower oil is characterized by a high ratio LA/a-LnA (1052).
Sunflower oil contained a higher proportion of trans-9,cis-12-18:2,
which represented 0.3% of the total fatty acids, as well as a higher
proportion of CLA trans-9,trans-11-18:2 than the linseed oil. These
observations will be taken into account when interpreting results
obtained in tissues and biological fluids.
Fatty acid profile in intestinal contents of oil force-fed
mice reveals a high availability of PUFA precursors
throughout the gut and a higher proportion of bacterial
metabolites in the caecum and colon than in the
jejunum or ileum
In the intestinal contents, the total fatty acid amount decreased
with progress down the gut. The total amount of fatty acid was
very high in the jejunum (117.9 mg fatty acids/mg of jejunum
content in linseed oil force-fed mice and 90.69 mg fatty acids/mg
of jejunum content in sunflower oil force-fed mice) and decreased
dramatically between jejunum and ileum (38 mg fatty acids/mg of
ileum content in linseed oil force-fed mice and 39.74 mg fatty
acids/mg of ileum content in sunflower oil force-fed mice). The
amounts of fatty acid found in ileum, caecum and colon contents
were similar.
In all the different intestinal contents (jejunum, ileum, caecum
and colon), varying amounts of LA and a-LnA were observed, in
accordance with the fatty acid profile of the ingested oil: a high
proportion of LA was observed in the group of mice that received
sunflower oil, and a high proportion of a-LnA in the group of mice
receiving linseed oil (Fig 1 A, G). Interestingly, oils force-feeding
increased the contents of LA and a-LnA at a similar extent in the
upper (jejunum and ileum contents) and lower (caecum and colon
contents) parts of the gut (Fig 1 A, G), suggesting that the quantity
of PUFA available for the bacterial metabolism was increased in
all intestinal contents after administration of oils.
Interestingly, LA and a-LnA-derived bacterial metabolites are
present in higher proportions in the content of the distal parts of
the gut (caecum and colon) than in the content of the proximal
parts of the gut (jejunum and ileum) (Fig 1 B-F, H-I).
The proportions of LA metabolites (such as rumenic acid,
vaccenic acid, CLA trans-10,cis-12-18:2 and CLA trans-9,trans-11-
18:2) were higher in the group of mice force-fed with sunflower oil
compared with the mice force-fed with linseed oil (Fig 1 B-E). The
proportions of a-LnA metabolites (such as CLnA cis-9,trans-11,cis-
15-18:3 and trans-11,cis-15-18:2) were higher in the group of mice
force-fed with linseed oil than in the group of mice force-fed with
sunflower oil (Fig 1 H,I; Figure S1). However, the GC method
with a single temperature program did not allow to clearly
separate the trans-11,cis-15-18:2 and the trans-9,cis-12-18:2. With
the two temperatures method, we observed that trans-9,cis-12-18:2
was not detectable in caecum content and caecum tissue of linseed
oil force-fed mice whereas it was detectable in the sunflower oil
force-fed mice, probably because it was supplied directly by the
PUFA-Derived Bacterial Metabolites Bioavailability
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sunflower oil (Figure S1 and Figure S2). As trans-9,cis-12-18:2 was
not detectable in caecum content and caecum tissue of the linseed
oil force-fed mice, we assumed that trans-11,cis-15-18:2 was
correctly identified only in this group of mice.
The monounsaturated bacterial metabolite called vaccenic acid
(trans-11-18:1) can be produced from both LA and a-LnA. In the
group of mice force-fed with sunflower oil, the proportion of
vaccenic acid in the caecal content was higher than in the three
other intestinal contents (jejunum, ileum and colon contents) (Fig 1
C). The vaccenic acid proportion in the caecal content was higher
in the sunflower oil force-fed mice than in the linseed oil force-fed
mice (Fig 1 C). This result could suggest that vaccenic acid is
mainly produced from bacterial metabolism of LA rather than
from bacterial metabolism of a-LnA. In other intestinal contents,
we did not observe any difference of vaccenic acid content
between the two groups of mice (Fig 1 C).
Fatty acid profile in intestinal tissues
As shown in intestinal contents, and in accordance with the oil
composition, the proportion of LA was higher in the sunflower oil
force-fed mice than in the linseed oil force-fed mice, but this
difference was significant in the jejunum and ileum tissues only
(not in the caecum and colon tissues) (Fig 2 A). The proportion of
a-LnA was higher in the linseed oil force-fed mice than in the
sunflower oil force-fed mice in all intestinal tissues (Fig 2 G).
The different bacterial metabolites reached the intestinal tissues.
Most of metabolites accumulated in the lower gut (from ileum to
the colon) (Fig 2 B-D, F, H, I). Rumenic acid (CLA cis-9,trans-11-
18:2), and vaccenic acid (trans-11-18:1), two main LA-derived
bacterial metabolites, and CLnA cis-9,trans-11,cis-15-18:3 and
trans-11,cis-15-18:2, two main a-LnA-derived bacterial metabo-
lites, accumulated mainly in the caecal tissue (Fig 2 B,C; H,I). The
proportions of trans-11,cis-15-18:2 and of CLnA cis-9,trans-11,cis -
15-18:3 (to a lesser extent) mostly increased in the caecal tissue of
linseed oil force-fed mice, and not in the colon (Fig 2 H,I) even if
the proportion in the caecum and colon contents were similar. For
none of the intestinal tissues, proportions of LA metabolites
(rumenic acid and vaccenic acid) differed between the two groups
of mice (Fig 2 B-D,F). The proportion of the a-LnA metabolite
(CLnA cis-9,trans-11,cis-15-18:3) measured in the jejunum, caecum
Figure 1. Fatty acid profile in intestinal contents. Linoleic acid, a-linolenic acid and PUFA-derived bacterial metabolites in intestinal contents
(jejunum content – ileum content – caecum content and colon content) of mice force-fed with linseed oil (rich in n-3 LnA) or sunflower oil (rich in n-6
LA). Results are expressed as a percentage of identified fatty acids. Data are mean 6 SEM. Linear mixed-effects model followed by contrasts assessed
the statistical difference between both the two oil force-feedings and the different intestinal contents. * superscripts show significant differences (p,
0.05) between linseed oil force-feeding and sunflower oil force-feeding in each intestinal content. Different small superscript letters show significant
differences (p,0.05) between intestinal contents in linseed oil force-fed mice. Different capital superscript letters indicate significant differences (p,
0.05) between intestinal contents in sunflower oil force-fed mice. trans-11,cis-15-18:2 was detected in linseed oil force-fed mice only.
doi:10.1371/journal.pone.0087560.g001
PUFA-Derived Bacterial Metabolites Bioavailability
PLOS ONE | www.plosone.org 4 January 2014 | Volume 9 | Issue 1 | e87560
and colon tissues was higher in the linseed oil compared with the
sunflower oil treated mice (Fig 2 H). Trans fatty acid isomers found
in the original oil (e.g. trans-9,trans-11-18:2 and trans-9,cis-12-18:2
in sunflower oil) mainly accumulated in the jejunum tissue of
sunflower oil force-fed mice (Fig 2E; Figure S1B), suggesting that
these dietary fatty acids are mainly absorbed in the jejunum.
Circulating Fatty acid profile
In order to know if the bacterial metabolites found in the
intestinal contents and in the intestinal tissues can exert some
systemic effects, we analyzed the availability of these lipophilic
metabolites in the blood. Mice were previously treated with LPL
inhibitor, Tyloxapol, allowing lipid accumulation in the blood.
The accumulation of lipids in blood is shown in Fig 3A (plasma
triglycerides) and 3B (plasma NEFA). Plasma triglycerides
increased directly after the Tyloxapol injection and until
240 min whereas the plasma NEFA increased immediately after
the oil force-feeding and did not further increased between
120 min and 240 min (Fig 3 A, B).
Ten minutes after force-feeding, plasma levels of LA and a-LnA
were similar in both groups of mice. Later, i.e. 120 and 240
minutes after force-feeding, the fatty acid profile in the circulating
lipids was in agreement with the fatty acid profile of the oils: we
found a higher proportion of LA in the blood of sunflower oil
force-fed mice and a higher proportion of a-LnA in the blood of
linseed oil force-fed mice (Fig 4 A, B).
Proportions of the three bacterial metabolites that accumulated
mainly in the caecal tissue (CLA cis-9,trans-11-18:2, CLnA cis-
9,trans-11,cis-15-18:3 and trans-11,cis-15-18:2) were not modified
by oil force-feeding, nor by the timing of the different blood
samplings (Data not shown). However, the proportions of CLA
trans-9,trans-11-18:2 and trans-9,cis-12-18:2, fatty acids that accu-
mulated in the jejunum tissue and were probably of dietary origin,
increased in a time-dependent way (Fig 4C, Fig S1C).
Discussion
We have previously shown that proportions of rumenic acid and
vaccenic acid were increased in caecal tissue and subcutaneous
adipose tissue of mice fed a HF diet or a HF diet supplemented
with prebiotic carbohydrates, that modulate the gut microbiota
composition [23,34]. This study suggests that those particular fatty
acids may be metabolites produced from dietary fatty acids by
Figure 2. Fatty acid profile in intestinal tissues. Linoleic acid, a-linolenic acid and PUFA-derived bacterial metabolites in intestinal tissues
(jejunum tissue – ileum tissue – caecum tissue and colon tissue) of mice force-fed with linseed oil (rich in n-3 LnA) or sunflower oil (rich in n-6 LA).
Results are expressed as a percentage of identified fatty acids. Data are mean 6 SEM. Linear mixed-effects model followed by contrasts assessed the
statistical difference between both the two oil force-feedings and the different intestinal tissues. * superscripts show significant differences (p,0.05)
between linseed oil force-feeding and sunflower oil force-feeding in each intestinal tissue. Different small superscript letters show significant
differences (p,0.05) between intestinal tissues in linseed oil force-fed mice. Different capital superscript letters indicate significant differences (p,
0.05) between intestinal tissues in sunflower oil force-fed mice. trans-11,cis-15-18:2 was detected in linseed oil force-fed mice only.
doi:10.1371/journal.pone.0087560.g002
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commensal bacteria and that those metabolites could have an
effect outside the gut. However, little is known about the
availability of dietary fatty acids in the distal parts of the gut and
the systemic bioavailability of PUFA-derived bacterial metabolites.
In the present in vivo experiment, we analyzed the fatty acid profile
in all the intestinal contents and intestinal tissues, in order to verify
if the precursors, LA and a-LnA, were effectively present in all the
intestinal contents, including the distal parts (caecum and colon
contents), where bacteria are the most abundant. A high
proportion of LA and a-LnA was observed in mice receiving
sunflower oil (rich in n-6 LA) and linseed oil (rich in n-3 LnA),
respectively; these changes occurring in all intestinal contents
(including caecum and colon contents). Although it is assumed that
95% of dietary lipids are absorbed in the proximal part of the gut
in physiologic conditions [27], our results suggest that oils were not
completely absorbed in the jejunum and ileum under our
experimental conditions. In a HF diet model, it has been shown
that an overflow of lipids reaches the distal part of the small
intestine, and so could also reach the colon [35]. Therefore, the oil
force-feeding is not representative for physiologic conditions but
rather mimics an overflow of lipids, as created in mice fed a HF
diet. Our protocol created a sufficient flow of substrates available
for bacterial metabolism in all intestinal segments.
Since all mice arrived at the same time, had the same genetic
background, ate the same food from weaning, and were randomly
assigned to one or the other oil before the force-feeding
experiment, we suppose that microbiota composition did not
differ significantly between the two groups of mice before the
experiment. Indeed, major differences in the composition of the
gut microbiota composition could have important impact on
PUFA-derived bacterial metabolites production. However, mod-
ifications of the gut microbiota composition could be induced by
the oil force-feedings. Indeed, arguments from the literature
suggest that the type of dietary fat is able to modulate the
composition of the gut microbiota [35–37]. It was shown that
saturated fatty acids induced more changes in the gut microbiota
composition than monounsaturated fatty acids or polyunsaturated
fatty acids [35]. Mujico et al have also shown that supplementation
with an oleic acid-derived compound is able to decrease body
weight gain and to restore the proportions of bacteria after HF diet
treatment [37]. However, in this short-term experiment, we did
not know if 4 hours are sufficient to change the gut microbiota
composition. So, the analysis of the gut microbiota composition
after the oil force-feeding represents a very interesting prospect to
the present study.
This study highlights for the first time that a production of
CLnA takes place in vivo and in agreement with the in vitro studies,
the main a-LnA metabolites seem to be CLnA cis-9,trans-11,cis-15-
18:3 and trans-11,cis-15-18:2 [8,15]. Proportions of the majority of
bacterial metabolites (LA metabolites and a-LnA metabolites)
were lower in the contents of the proximal parts of the gut
(jejunum and ileum contents) than in the contents of the distal
parts of the gut (caecum and colon contents) where the density and
the diversity of the gut microbiota are the highest [24,38,39]. In
view of these results, we postulate that these metabolites are
produced by bacterial metabolism rather than supplied by the diet.
In the caecum content, the production of PUFA-derived
bacterial metabolites is influenced both by the quantity and the
nature (n-3 PUFA versus n-6 PUFA) of the dietary fatty acids.
Indeed, we found higher proportions of CLnA cis-9,trans-11,cis-15-
18:3 and trans-11,cis-15-18:2 in the mice force-fed with linseed oil
(rich in n-3 PUFA) whereas we observed a higher proportion of
rumenic acid (CLA cis-9,trans-11-18:2), vaccenic acid (trans-11-
18:1) and CLA trans-9,trans-11-18:2 in mice force-fed with
sunflower oil (rich in n-6 PUFA). These observations were already
found in ruminants where the biohydrogenation pathways of LA
and a-LnA are quite well characterized [40], suggesting that a
Figure 3. Blood lipids accumulation. Triglycerides and non-
esterified fatty acids (NEFA) were measured just before the Tyloxapol
injection (T-30), just before oil force-feeding (T0), ten minutes (T10),
2 hours (T120) and 4 hours (T240) after oil force-feeding in the plasma
of mice force-fed with linseed oil (rich in n-3 LnA) or sunflower oil (rich
in n-6 LA). Data are mean 6 SEM. Linear mixed-effects model followed
by contrasts assessed the statistical difference between both the two oil
force-feedings and the blood sample times. Differences between
linseed oil force-fed mice and sunflower oil force-fed mice were not
significant at any of the blood sample times. Grey small superscript
letters show significant differences (p,0.05) between blood sample
times in linseed oil force-fed mice. Black major superscript letters show
significant differences (p,0.05) between the blood sample times in
sunflower oil force-fed mice.
doi:10.1371/journal.pone.0087560.g003
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similar ‘‘biohydrogenation pathway’’ could take place in mam-
malian gut, even if the two microbial environments are different.
The production of one particular PUFA-derived bacterial
metabolite, CLA cis-9,cis-11-18:2, seems to be influenced by both
the intestinal segment and the nature of the dietary fatty acid.
Indeed, the proportion of CLA cis-9,cis-11-18:2 in the ileum
content was higher in the sunflower oil force-fed mice than in the
linseed oil force-fed mice whereas its proportion in the contents of
the distal parts of the gut (caecum and colon contents) tended to be
higher in the linseed oil force-fed mice than in the sunflower oil
force-fed mice. According to the ruminant biohydrogenation
pathways proposed by Chilliard Y. et al, the CLA cis-9,cis-11-18:2
could be a metabolite produced from both LA and a-LnA [6].
This observation could explain the differences between the
intestinal segments since the bacterial population of the different
intestinal segments seems to be different [41].
Our results suggest that PUFA-derived bacterial metabolites are
mainly produced in the distal part of the gut. However, the main
place of lipid absorption remains the small intestine [27]. We
confirm this since a two-fold decrease of total fatty acid amount
was observed between jejunum and ileum contents; suggesting that
a large part of the fatty acids present in the intestinal lumen are
absorbed in the jejunum. To study the bioavailability of PUFA-
derived bacterial metabolites, we focused on their accumulation in
intestinal tissues and in peripheral plasma. In the intestinal tissues,
the majority of the bacterial metabolites accumulated in the
caecum tissue which is in agreement with the higher proportion of
these metabolites in the caecum content. However, the propor-
tions of some bacterial metabolites such as rumenic acid (CLA cis-
9,trans-11-18:2), CLnA cis-9,trans-11,cis-15-18:3 and trans-11,cis-15-
18:2 were similar in the caecum and colon contents. In intestinal
tissues, the proportions of these bacterial metabolites were higher
in the caecum tissue than in the colon tissue, suggesting that the
caecal tissue has a higher capacity of up-take than the colon tissue.
This observation could be explained by the thicker layer of mucus
in the colon than in the caecum [42]. The mucus layer could
interfere with the fatty acid up-take by intestinal cells. However,
for these bacterial metabolites that accumulated mainly in the
caecum tissue, their bioavailability, revealed by analysis of
circulating lipids, was not influenced neither by the type of oil
used nor by the timing of blood samples. These results suggest that
these bacterial metabolites could exert rather local effects in
intestinal tissues of host than direct systemic effects.
However, changes in fatty acid profile in intestinal tissues could
have effects on host’s physiology, namely by interactions with cell
membrane receptors like G protein-coupled receptors (GPR) or
with nuclear receptor such as peroxisome proliferator-activated
receptors (PPAR). On one hand, it was shown that several GPRs,
such as GPR40 and GPR120, which are expressed in the
gastrointestinal tissues, could be considered as fat sensors [43].
Schmidt et al have shown that two CLA isomers, CLA cis-9,trans-
11-18:2 and CLA trans-10,cis-12-18:2 are full GRP40 agonists [44].
Activation of GPR40 in enteroendocrine cells increases incretins
production by these cells [45]. GPR120 was also shown to be able
to increase incretins production after activation by lipid agonist,
such as linoleic and a-linolenic acid [46]. However, the ability of
CLA or CLnA to bind GPR120 has not been demonstrated yet. It
could be very interesting to test the hypothesis that PUFA-derived
bacterial metabolites, by acting as GPR40 and/or GPR120
agonists, could thus modulate host metabolism, namely by
changing incretins production. On the other hand, PPARc is
expressed at the intestinal level and activation of this receptor by
CLA is associated with a decreased of inflammation in murine
model of inflammatory bowel diseases [47]. So, the activation of
these receptors by PUFA-derived bacterial metabolism at the
intestinal level could have an effect on host metabolism or host
inflammation.
In a previous study, we described an accumulation of PUFA-
derived bacterial metabolites in adipose tissue [34]. It might be
possible that under pathologic conditions characterized by an
alteration of the gut barrier function such as in HF diet conditions
[48] or inflammatory bowel diseases [24], these PUFA-derived
bacterial metabolites could cross the gut epithelium and reach the
systemic bloodstream in a higher quantity than under physiologic
conditions. Indeed, it has been shown that HF diet treatment
increases gut permeability and thereby promotes the paracellular
translocation of lipophilic molecules, such as lipopolysaccharides
(LPS), lipophilic components of the gram-negative bacterial cells
[48]. Under HF diet treatment, it is likely that other lipophilic
bacterial metabolites (e.g. CLA and CLnA) could cross the gut
epithelium in this way and reach the lymphatic or portal
circulation.
Contrary to the PUFA-derived bacterial metabolites that were
undetectable in oils and that accumulated mainly in the caecum
tissue, two fatty acids, CLA trans-9,trans-11-18:2 and trans-9,cis-12-
18:2, accumulated mainly in the jejunum tissue of sunflower oil
Figure 4. Fatty acid profile in circulating lipids. Linoleic acid, a-linolenic acid and PUFA-derived bacterial metabolites in peripheral plasma of
mice force-fed with linseed oil (rich in n-3 LnA) or sunflower oil (rich in n-6 LA) at different timing after the force-feeding (10 minutes; 120 minutes
and 240 minutes after the force-feeding). Results are expressed as a percentage of identified fatty acids. Data are mean 6 SEM. Linear mixed-effects
model followed by contrasts assessed the statistical difference between both the two oil force-feedings and the blood sample times. * superscripts
show significant differences (p,0.05) between linseed oil force-feeding and sunflower oil force-feeding at each blood sample time. Different small
superscript letters show significant differences (p,0.05) between blood sample times in linseed oil force-fed mice. Different capital superscript letters
indicate significant differences (p,0.05) between blood sample times in sunflower oil force-fed mice. trans-11,cis-15-18:2 was detected in linseed oil
force-fed mice only.
doi:10.1371/journal.pone.0087560.g004
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force-fed mice probably because these fatty acids are supplied by
the sunflower oil. This suggests that the jejunum tissue fatty acid
profile reflects the oil fatty acid profile rather than an accumu-
lation of PUFA-derived bacterial metabolites produced in situ. In
circulating lipids (120 and 240 minutes after force-feeding), the
proportions of both fatty acids are higher in the sunflower oil
force-fed mice than in the linseed oil force-fed mice. Furthermore,
in the sunflower oil force-fed mice, the proportion of these fatty
acids increased in a time dependent manner, suggesting that they
are absorbed from the jejunum. We propose that among the fatty
acids present in the diet, or produced upon bacterial metabolism,
only those accumulating in the jejunum tissue can be effectively
absorbed. Thus our data suggests that the systemic bioavailability
of the PUFA-derived bacterial metabolites produced in the lower
part of the gut remains negligible.
Finally, in view of the results obtained in this experiment, we are
able to validate and extend our knowledge on gut microbial
metabolism occurring in vivo in rodents from dietary PUFA. Before
our studies, the proposed pathways were suggested from in vitro
studies, or extrapolated from studies performed in ruminants
[6,7,11,23] (Fig 5). The relevance of those pathways in humans
would be interesting to evaluate in the future.
Supporting Information
Figure S1 Sum of trans-9,cis-12-18:2 and trans-11,cis-
15-18:2 in intestinal contents, intestinal tissues and
circulating lipids of the sunflower oil force-fed mice.
The results are expressed as a percentage of identified fatty acids.
Data are mean 6 SEM. Statistical significance of differences
between intestinal contents, intestinal tissues and blood samples
times were assessed by one-way ANOVA followed by Bonferroni’s
post-hoc multiple comparison test. Values with unlike superscript
letters are significantly different (p,0.05).
(TIF)
Figure S2 trans-9,cis-12-18:2 and trans-11,cis-15-18:2 in
caecum content and caecum tissue analyzed by the GC
method combining two temperature program. The results
are expressed as a percentage of identified fatty acids. Data are
mean 6 SEM. Statistical significance of difference between oil
force-feedings was assessed by Student t-test (** p,0.01; *** p,
0.001).
(TIF)
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